Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

MA-2029

Cat. No.: IBDI-433992

MA-2029 is a selective, orally active, and competitive motilin receptor antagonist (IC50=4.9 nM). MA-2029 is selective for the motilin receptor over various other receptors and ion channels. MA-2029 may be useful for gastrointestinal disorders associated with disturbed gastrointestinal motility.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid):

Product Details

Target Motilin Receptor
Molecular Weight 556.71
Appearance Solid
SMILES FC(C=C1)=CC=C1C[[email protected]](NC)C(N(C)[[email protected]@H](C(C)C)C(N[[email protected]](C(NCC)=O)CC2=CC(C(C)(C)C)=C(O)C=C2)=O)=O

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.